Sustainable Solutions for Disposable E-Cigarettes in the UK

May.14.2023
Sustainable Solutions for Disposable E-Cigarettes in the UK
Multiple eco-friendly solutions launched by e-cigarette companies at Birmingham Expo to address the issue of disposable e-cigarette waste.

Special announcement:


This article is intended for industry research and exchange only, and does not endorse any brands or products. Minors are prohibited from accessing it.


Recently, single-use e-cigarettes have sparked public concern in the UK due to their impact on the environment. Mainstream newspapers such as the Financial Times have reported on the issue of resource waste caused by single-use e-cigarettes. Despite their appeal in terms of portability and convenience, the disposable nature of these devices has led to a significant amount of waste and resource depletion. To address this issue, manufacturers are taking green action plans to promote the sustainable development of the e-cigarette industry.


On May 13th, the 2FIRSTS London News Centre learned at the Birmingham Electronic Cigarette Exhibition in the UK that several well-known companies presenting at the event unveiled their environmental protection plans. These included a complete recycling system by Smoore and YOOZ, ELUX's Recovery Bucket, and Flonq's recyclable electronic cigarette device, Flonq Plus-E.


Simor Alliance and Yueke launch a full-cycle recycling system.


At an electronic cigarette exhibition in Birmingham, UK, Smoore announced its partnership with client Yooz to launch the first-ever comprehensive end-to-end recycling system for disposable products worldwide. The system involves the participation of manufacturers, brand owners, retailers, consumers, and compliance processing agencies. Consumers can use express delivery companies or retail stores to recycle used disposable products and receive corresponding benefits. Moreover, the professional recycling agency collaborating with Smoore will provide environmentally friendly solutions that involve 100% deconstruction and zero landfill. Smoore stated that this system can greatly reduce the environmental impact of disposable products and achieve sustainable development in the industry.


Smorrow Exhibit Booth | Image Source: 2FIRSTSELUX plans to invest in 200,000 recycling bins.


Onsite employees from ELUX informed 2FIRSTS at the Birmingham exhibition that the company plans to introduce an eco-friendly program to address the environmental impact of disposable electronic cigarettes.


According to reports, ELUX has designed special recycling bins and plans to place 200,000 of them in e-cigarette stores throughout the UK this year, specifically for the purpose of recycling disposable e-cigarette products (regardless of brand), which will then be transported to Indonesia for processing. In addition, ELUX staff have stated that for every e-cigarette collected, they will donate 0.1 US dollars to charity.


Caption: ELUX Recycling Bin | Photo Source: 2FIRSTS The above caption describes an ELUX recycling bin and credits the photo source as 2FIRSTS.


Flonq has launched a recyclable electronic cigarette device, Flonq Plus-E.


At the exhibition, Flonq launched its first recyclable electronic cigarette device, the Flonq Plus-E. The device can be easily disassembled for recycling after use. Its unique design includes a detachable battery located at the bottom and a patented child lock system to prevent unauthorized use by children and teenagers.


Recyclable device Flonq Plus-E | Image source: 2FIRSTS


Cover Image: Photograph by 2FIRSTS.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Trump Names Darrell Scott as CDC Tobacco Health Adviser, Citing Tobacco Risks and Harm-Reduction Solutions
Trump Names Darrell Scott as CDC Tobacco Health Adviser, Citing Tobacco Risks and Harm-Reduction Solutions
U.S. President Donald Trump has named Pastor Darrell Scott to serve as an adviser on tobacco health issues on the Centers for Disease Control and Prevention’s Advisory Committee to the Director. Trump said Scott would focus on the burden of tobacco-related disease and help examine ways to protect Americans from dangerous tobacco products while supporting solutions that reduce harm. Scott’s public career has largely centered on faith leadership, community advocacy and politics.
Sep.02
Australian Coalition Taskforce Calls for 80% Tobacco Tax Cut to Combat Illicit Market
Australian Coalition Taskforce Calls for 80% Tobacco Tax Cut to Combat Illicit Market
According to SGST on August 26, 2026, Australia’s Coalition Illegal Tobacco Taskforce released a report recommending an up to 80% cut in tobacco excise to reduce the appeal of the illicit tobacco market. The report claimed organised crime groups now control about 80% of Australia’s tobacco market and argued that high excise rates have widened the price gap between legal and illegal products. The recommendation remains a policy proposal and has not been adopted by the Australian government, which said its focus remains on enforcement, compliance and additional resources.
Aug.27
Australia Extends Illicit Tobacco Crackdown From Tougher Penalties to Customs and Logistics Supply Chains
Australia Extends Illicit Tobacco Crackdown From Tougher Penalties to Customs and Logistics Supply Chains
Australia's federal government introduced a new illicit tobacco enforcement bill on September 10 that would strengthen evidentiary presumptions, representative sampling, seizure and forfeiture procedures, proceeds-of-crime powers and obligations for customs and logistics operators. The proposal follows the Combatting Illicit Tobacco Act 2026, which took effect in August and increased penalties while expanding investigative and asset-recovery tools. Together, the reforms extend Australia's crackdown from tougher criminal sanctions into import, logistics and evidentiary enforcement.
Sep.14
Zhang Xiaotang Appointed Deputy Director of China’s Tobacco Regulator, Adding Another Finance-Background Official to Top Leadership
Zhang Xiaotang Appointed Deputy Director of China’s Tobacco Regulator, Adding Another Finance-Background Official to Top Leadership
China’s State Council has appointed Zhang Xiaotang as deputy director of the State Tobacco Monopoly Administration, with the regulator’s official website now listing him as a Party leadership group member and deputy director. Zhang previously led Hebei China Tobacco and earlier headed the STMA’s finance and audit department. His appointment follows the elevation earlier this year of former tax official Yao Laiying to head the STMA, adding another senior official with a strong fiscal or financial-management background to China Tobacco’s top leadership in 2026.
News
Sep.20
FDA Unifies Tobacco Registration and Product Listing Form Across Product Categories
FDA Unifies Tobacco Registration and Product Listing Form Across Product Categories
The U.S. FDA has consolidated two tobacco establishment registration and product listing forms into a redesigned Form FDA 3741 covering all regulated product categories, including e-cigarettes, heated tobacco products and nicotine pouches. The current requirements remain limited to domestic establishments. Separately, the FDA has proposed extending registration and product listing requirements to foreign manufacturers, signaling greater regulatory attention to manufacturing entities and product-level information across the tobacco and nicotine supply chain.
FDA
Sep.30
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Eleftheria (Ria) Kioupritzi, a biopharmaceutical professional with more than 15 years of experience, has joined Philip Morris International as Director Scientific Affairs within Corporate Affairs. She previously served at Roche as Senior Scientific Communications Director for Neuroscience and Rare Diseases and worked extensively in spinal muscular atrophy. Her earlier career also covered competitive intelligence, clinical and regulatory monitoring, pipeline development and launch preparation. During her time working in Roche's SMA field, Evrysdi passed through several U.S. FDA milestones, including its initial approval, an expanded indication for younger infants and approval of a tablet formulation. Public records do not show that Kioupritzi herself led the FDA submissions.
Sep.22